32 research outputs found

    Changes to serum sample tube and processing methodology does not cause inter-individual variation in automated whole serum N-glycan profiling in health and disease

    Get PDF
    Serum N-glycans have been identified as putative biomarkers for numerous diseases. The impact of different serum sample tubes and processing methods on N-glycan analysis has received relatively little attention. This study aimed to determine the effect of different sample tubes and processing methods on the whole serum N-glycan profile in both health and disease. A secondary objective was to describe a robot automated N-glycan release, labeling and cleanup process for use in a biomarker discovery system.25 patients with active and quiescent inflammatory bowel disease and controls had three different serum sample tubes taken at the same draw. Two different processing methods were used for three types of tube (with and without gel-separation medium). Samples were randomised and processed in a blinded fashion. Whole serum N-glycan release, 2-aminobenzamide labeling and cleanup was automated using a Hamilton Microlab STARlet Liquid Handling robot. Samples were analysed using a hydrophilic interaction liquid chromatography/ethylene bridged hybrid(BEH) column on an ultra-high performance liquid chromatography instrument. Data were analysed quantitatively by pairwise correlation and hierarchical clustering using the area under each chromatogram peak. Qualitatively, a blinded assessor attempted to match chromatograms to each individual.There was small intra-individual variation in serum N-glycan profiles from samples collected using different sample processing methods. Intra-individual correlation coefficients were between 0.99 and 1. Unsupervised hierarchical clustering and principal coordinate analyses accurately matched samples from the same individual. Qualitative analysis demonstrated good chromatogram overlay and a blinded assessor was able to accurately match individuals based on chromatogram profile, regardless of disease status.The three different serum sample tubes processed using the described methods cause minimal inter-individual variation in serum whole N-glycan profile when processed using an automated workstream. This has important implications for N-glycan biomarker discovery studies using different serum processing standard operating procedures

    Zero-shot adaptation for mmWave beam-tracking on overhead messenger wires through robust adversarial reinforcement learning

    No full text
    Abstract Millimeter wave (mmWave) beam-tracking based on machine learning enables the development of accurate tracking policies while obviating the need to periodically solve beam-optimization problems. However, its applicability is still arguable when training-test gaps exist in terms of environmental parameters that affect the node dynamics. From this skeptical point of view, the contribution of this study is twofold. First, by considering an example scenario, we confirm that the training-test gap adversely affects the beam-tracking performance. More specifically, we consider nodes placed on overhead messenger wires, where the node dynamics are affected by several environmental parameters, e.g., the wire mass and tension. Although these are particular scenarios, they yield insight into the validation of the training-test gap problems. Second, we demonstrate the feasibility of zero-shot adaptation as a solution, where a learning agent adapts to environmental parameters unseen during training. This is achieved by leveraging a robust adversarial reinforcement learning (RARL) technique, where such training-and-test gaps are regarded as disturbances by adversaries that are jointly trained with a legitimate beam-tracking agent. Numerical evaluations demonstrate that the beam-tracking policy learned via RARL can be applied to a wide range of environmental parameters without severely degrading the received power
    corecore